A young specialist explores a paradigm shift in the cyclical 'treat, respond, relapse, repeat' approach to therapy for ...

Long-term results of a phase 3 trial show that early rituximab monotherapy significantly delays the need for new treatment in ...

Long-term results from a randomized trial confirmed that early rituximab monotherapy for advanced-stage, asymptomatic, low ...

A next-generation, anti-CD19 enhanced (or "armored") CAR T-cell product showed promising efficacy and safety in a phase I ...

Watchful waiting—also known as active surveillance—is a common approach for asymptomatic, advanced stage follicular lymphoma, ...

Prakash Patel is currently undergoing chemotherapy for follicular lymphoma cancer and unexpectedly had his Lloyds bank account closed.

Four years after remission from follicular lymphoma, ongoing fear of relapse, lingering symptoms, and life stressors continue ...

Genmab (Nasdaq: GMAB) posted a 19% rise in revenue to $715 million for the first quarter of 2025, driven by higher royalties ...

Remission indicates symptom disappearance, not a cure, especially in chronic diseases like follicular lymphoma. Blood cancers are challenging to eradicate due to their systemic nature, requiring ...

During a live event, Krish Patel, MD, surveyed participants on using bispecific T-cell engagers vs loncastuximab in a patient ...